Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - Fibrocell Science, Inc. | fcsc-20151231ex231.htm |
| EX-21 - EXHIBIT 21 - Fibrocell Science, Inc. | fcsc-20151231ex21.htm |
| EX-32.1 - EXHIBIT 32.1 - Fibrocell Science, Inc. | fcsc-20151231ex321.htm |
| EX-32.2 - EXHIBIT 32.2 - Fibrocell Science, Inc. | fcsc-20151231ex322.htm |
| EX-31.2 - EXHIBIT 31.2 - Fibrocell Science, Inc. | fcsc-20151231ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Fibrocell Science, Inc. | fcsc-20151231ex311.htm |
| 10-K - FORM 10-K - Fibrocell Science, Inc. | annualreportonform10-kasof.htm |
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Fibrocell Science, Inc.
Exton, Pennsylvania
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-183792, No. 333-183793, No. 333-183794, No. 333-185463, No. 333-185466, No. 333-190649 and No. 333-209077), and Form S-8 (No. 333-172776, No. 333-190650 and No. 333-196964) of Fibrocell Science, Inc. of our report dated March 13, 2015, relating to the 2014 and 2013 consolidated financial statements of Fibrocell Science Inc., which appear in this Form 10-K.
/s/ BDO USA, LLP |
Philadelphia, Pennsylvania |
March 10, 2016 |